4.49
Schlusskurs vom Vortag:
$4.36
Offen:
$4.35
24-Stunden-Volumen:
111.58K
Relative Volume:
0.54
Marktkapitalisierung:
$83.10M
Einnahmen:
$119.48M
Nettoeinkommen (Verlust:
$-81.65M
KGV:
-0.6598
EPS:
-6.8055
Netto-Cashflow:
$-47.13M
1W Leistung:
+1.70%
1M Leistung:
+11.85%
6M Leistung:
-64.88%
1J Leistung:
-63.39%
Outset Medical Inc Stock (OM) Company Profile
Firmenname
Outset Medical Inc
Sektor
Branche
Telefon
669-231-8200
Adresse
3052 ORCHARD DRIVE, SAN JOSE
Compare OM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
OM
Outset Medical Inc
|
4.485 | 80.79M | 119.48M | -81.65M | -47.13M | -6.8055 |
|
ABT
Abbott Laboratories
|
88.29 | 155.82B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
292.13 | 112.88B | 25.27B | 3.34B | 4.57B | 8.6358 |
|
MDT
Medtronic Plc
|
79.27 | 102.71B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
57.38 | 83.97B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
84.25 | 48.42B | 6.30B | 1.07B | 1.34B | 1.8406 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Eingeleitet | BTIG Research | Buy |
| 2024-04-05 | Hochstufung | CL King | Neutral → Buy |
| 2024-01-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-08-17 | Eingeleitet | CL King | Neutral |
| 2022-11-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-07-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Eingeleitet | Cowen | Outperform |
| 2021-04-19 | Eingeleitet | Wells Fargo | Overweight |
| 2020-12-16 | Eingeleitet | Oppenheimer | Perform |
| 2020-10-12 | Eingeleitet | Barclays | Overweight |
| 2020-10-12 | Eingeleitet | BofA Securities | Buy |
| 2020-10-12 | Eingeleitet | Goldman | Buy |
| 2020-10-12 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-10-12 | Eingeleitet | Stifel | Buy |
Alle ansehen
Outset Medical Inc Aktie (OM) Neueste Nachrichten
Outset Medical (OM) price target decreased by 14.29% to 9.18 - MSN
Reid Health team targets manual charting reductions through Outset Medical EMR integration - Traders Union
Outset Medical (OM) to Release Quarterly Earnings on Wednesday - MarketBeat
Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026 - The Manila Times
Outset Medical sets May 7 investor call with CEO, CFO - Stock Titan
Outset Medical Q4 2025 earnings preview - MSN
Outset Medical (NASDAQ: OM) details 2026 meeting, board elections and exec pay - Stock Titan
Does Outset Medical (OM) stock justify its current price (Near Highs) 2026-04-20Insider Info - Cổng thông tin điện tử Tỉnh Sơn La
AI Models Turn Cautiously More Positive on Outset Medical as Turnaround Takes Shape - TipRanks
Should investors consider Outset Medical (OM) stock right now (Technical Strength) 2026-04-18Swing Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Outset Medical, Inc. (OM) Stock Analysis: Exploring a Healthcare Play with 106.90% Potential Upside - DirectorsTalk Interviews
RBC Capital Keeps Their Hold Rating on Outset Medical (OM) - The Globe and Mail
RBC Capital Maintains Outset Medical(OM.US) With Hold Rating, Maintains Target Price $7 - Moomoo
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - GuruFocus
Outset Medical (NASDAQ:OM) Stock Rating Lowered by Wall Street Zen - MarketBeat
Outset Medical, Inc. (NASDAQ:OM) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Is Outset Medical (OM) Stock Showing Strength | Price at $4.18, Down 0.48%Community Picks - Xã Thanh Hà
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule - National Today
Outset Medical Reports Nasdaq Inducement Grant - National Today
Outset Medical (OM) EVP granted 96,000 restricted stock units in equity award - Stock Titan
Outset Medical (OM) EVP Elliott Derick A. files initial Form 3 insider report - Stock Titan
Outset Medical gives new commercial chief 96,000 stock units - Stock Titan
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Outset Medical, Inc. (NASDAQ:OM) Position Lowered by National Bank of Canada FI - 富途牛牛
TD Cowen Initiates Outset Medical(OM.US) With Buy Rating, Announces Target Price $12 - Moomoo
Outset Medical adds former Stryker leader as new EVP of commercial - MassDevice
Outset Medical names Derick Elliott commercial chief By Investing.com - Investing.com Canada
Outset Medical Names Derick Elliott as Executive Vice President of Commercial - National Today
Outset Medical names Derick Elliott commercial chief - Investing.com
Outset brings in ex-Stryker leader as Tablo expands across hospitals - Stock Titan
Outset Medical, Inc. Appoints Derick Elliott as Executive Vice President of Commercial, Effective April 6, 2026 - marketscreener.com
Market Moves: Is Outset Medical Inc stock risky to hold nowTrade Performance Summary & AI Driven Stock Price Forecasts - baoquankhu1.vn
Should I Hold Outset Medical (OM) Stock Now | Price at $4.07, Up 1.50%Post Earnings - Cổng thông tin điện tử tỉnh Lào Cai
OM Stock Analysis: Outset Medical Inc gains 4.43 pct to hit 4.01 price point - Xã Thanh Hà
Outset Medical, Inc. (OM) Stock Analysis: Exploring a 173% Potential Upside with Innovative Hemodialysis Solutions - DirectorsTalk Interviews
OM PE Ratio & Valuation, Is OM Overvalued - Intellectia AI
Outset Medical Gets Investor Suit Over Device Approval Trimmed - Bloomberg Law News
ETF Watch: Can Outset Medical Inc sustain earnings growthWeekly Risk Report & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Outset Medical (NASDAQ:OM) Upgraded at Wall Street Zen - MarketBeat
Vanguard realigns reporting; Outset Medical (OM) shows 0% stake - Stock Titan
Resistance Check: What is Outset Medical Incs 5 year growth outlookRecession Risk & Daily Technical Forecast Reports - baoquankhu1.vn
If You Invested $1,000 in Outset Medical, Inc. (OM) - Stock Titan
OM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
OM.O Technical Analysis & Stock Price Forecast - Intellectia AI
Outset Medical to detail in-house dialysis rollout and nurse impact at AONL2026 - Traders Union
OM SEC FilingsOutset Medical, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Outset Medical, Inc. (OM) Stock Analysis: Exploring a 213% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
Why Did Outset Medical Stock Tumble Today? - MSN
Outset Medical bets on workflow efficiency gains with Tablo Dialysis during AONL2026 - tradersunion.com
Analyst sentiment on Outset Medical (OM) remains strong following Q4 results - MSN
Short Interest in Outset Medical, Inc. (NASDAQ:OM) Drops By 13.6% - MarketBeat
Finanzdaten der Outset Medical Inc-Aktie (OM)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):